contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


pharma-equity-group-helarsregnskab-2024-samt-guidance-2025

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

CEO, Sweden

Claus Thestrup

Pharma Equity Group develops new medicines for the local treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The company uses repositioning of existing drugs and brings drug candidates to a clinical phase III stage, after which it is handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the company.

Pharma Equity Group

Pharma Equity Group: Helårsregnskab 2024 samt guidance 2025

Hel&#xe5;ret 2024:
Selskabet rapporterer et underskud p&#xe5; DKK -24,4 mio. vs. DKK -24,3 mio. i 2023, I det konsoliderede resultat for 2024 er medtaget omkostninger d&#xe6;kkende for hele 2024 hvor der for sammenlignings&#xe5;ret 2023, grundet transaktionen med Reponex Pharmaceuticals A/S den 24. marts 2023, kun er tale om medtagne omkostninger for 9 m&#xe5;neder.
Det likvide beredskab per 31.12.2024 er DKK 4,2 mio.
St&#xf8;rre begivenheder efter &#xe5;rsregnskabsafslutningen:
Selskabet har styrket sit kapitalberedskab med DKK 13 mio. gennem l&#xe5;n og l&#xe5;netilsagn. Det giver selskabet en runway p&#xe5; 12 m&#xe5;neder.
Selskabet har valgt at fokusere p&#xe5; f&#xf8;lgende pipeline kandidater, tidligere udmeldt den 13. December 2024:
<ul style="margin-top: 0cm" type="disc">
<li class="MsoNormal" style=" mso-list: l0 level1 lfo1">RNX-051 til tyktarmsadenomer og tyktarmskr&#xe6;ft</li>
<li class="MsoNormal" style=" mso-list: l0 level1 lfo1">RNX-011 til behandling af bughindebet&#xe6;ndelse</li>
<li class="MsoNormal" style=" margin-bottom: 10.0pt; mso-list: l0 level1 lfo1">RNX-041 til behandling af IBD (pouchitis)</li>
</ul>
Guidance 2025:
Partneraftale i Q3 eller Q4 p&#xe5; DKK 11 mio.
Resultat f&#xf8;r skat p&#xe5; DKK -4 mio. til -7 mio.
Ingen forventninger til Portinho i guidance
L&#xe6;s hele meddelelsen her: <a href="https://pharmaequitygroup.com/news-and-press/" target="_blank" rel="noopener">&#xc5;rsregnskab 2024</a>
Deltag i dagens event med CEO Thomas K. Sels&#xf8; i dag kl 13 her: <a href="https://www.inderes.dk/videos/pharma-equity-group-opdatering-pa-helaret-2024" target="_blank" rel="noopener">Dagens event med PEG</a>
Dsiclaimer: HC Andersen Capital modtager betaling fra Pharma Equity Group for en Digital IR/Corporate Visibility abonnementsaftale./Claus Thestrup 20.03.2025, kl. 08:50.